IMGN Financial Facts

Total revenues: 19.71M
License and milestone fees: 10.08M
See Full Income Statement

Property and equipment, net of accumulated depreciation: 22.4M
Accumulated deficit: -807.77M
See Full Balance Sheet

Immunogen Inc. (IMGN) Earnings

  |   Expand Research on IMGN
Next EPS Date 8/2/16 *Est. EPS Growth Rate -48.0% *Last Qtr.
Average EPS % Beat Rate -33.9% Revenue Growth Rate +72.8% *Last Qtr.
Average % Move 1-Wk after EPS -10.6% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/29/16 Q316 -$0.37-$0.32 -$0.05$19.7M$23.02M N/A Details
1/29/16 Q216 -$0.38-$0.36 -$0.02N/A$17.87M N/A Details
10/27/15 Q116 -$0.39-$0.35 -$0.04$14.9M$15.84M N/A Details
7/31/15 Q415 -$0.71-$0.35 -$0.36$12.61M$15.42M N/A Details
4/24/15 Q315 -$0.25-$0.24 -$0.01$11.4M$20.95M N/A Details
1/30/15 Q215 $0.16-$0.05 +$0.21$48.3M$37.3M N/A Details
10/24/14 Q115 -$0.26-$0.15 -$0.11$13.2M$21.8M N/A Details
8/1/14 Q414 -$0.83-$0.32 -$0.51$5.74M$9.72M N/A Details